In theory we should be at about the low point as our funding costs went up ahead of our charged rates, so all else being equal our NIM should improve from here. And if this is the low point then that's not bad.
The "all else being equal" part contains a separate risk though of economic conditions worsening, and either bad debts increase or new loan volume decreases or both.
I'd say company performance seems solid but it's the macro conditions that worry me.
- Forums
- ASX - By Stock
- SVR
- Ann: FY24Q1 Trading Update
SVR
solvar limited
Add to My Watchlist
1.79%
!
$1.65

Ann: FY24Q1 Trading Update, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.65 |
Change
-0.030(1.79%) |
Mkt cap ! $324.1M |
Open | High | Low | Value | Volume |
$1.68 | $1.69 | $1.64 | $1.053M | 628.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6500 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.67 | 15043 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 18500 | 1.600 |
1 | 328 | 1.585 |
3 | 9998 | 1.580 |
3 | 11643 | 1.550 |
1 | 8000 | 1.545 |
Price($) | Vol. | No. |
---|---|---|
1.670 | 15043 | 2 |
1.675 | 2998 | 1 |
1.680 | 500 | 1 |
1.685 | 3323 | 1 |
1.690 | 108336 | 2 |
Last trade - 16.12pm 25/06/2025 (20 minute delay) ? |
Featured News
SVR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online